Earnings expectations are rising for FTSE 100 bottler Coca-Cola HBC

Investors seeking to refresh portfolios ahead of an anticipated global recovery in the New Year should buy shares in Coca-Cola HBC (CCH), the...

Thu, 17/12/2020 - 00:00


Why aren’t investors cheering AstraZeneca’s bid for Alexion?

At first glance AstraZeneca’s (AZN) $39.4 billion takeover offer for immunology and rare diseases specialist Alexion looks to be opportunistic and financially sound,...

Thu, 17/12/2020 - 00:00


Marketing of high-risk mini-bonds banned from 2021

The Financial Conduct Authority (FCA) is to permanently ban the mass-marketing of ‘speculative illiquid securities’ – including mini-bonds – to retail investors from...

Thu, 17/12/2020 - 00:00


More upgrades from trusty consumer favourite UPGS

UP Global Sourcing (UPGS) 115p

Gain to date: 22.7%
Original entry point: Buy at 93.7p, 27 August 2020


Since publishing its...

Thu, 17/12/2020 - 00:00


GlaxoSmithKline vaccine delay and Novacyt's new virus strain test

GlaxoSmithKline (GSK) £14.00

Gain to date: 6%
Original entry point: Buy at £13.21, 5 November 2020


Novacyt (NCYT:AIM) 870.2p

Gain...

Thu, 17/12/2020 - 00:00


The outlook for FTSE 100 dividends in 2021

It is unlikely that too many investors will make listening to more announcements from regulators one of their New Year’s resolutions, but no-one could accuse...

Thu, 17/12/2020 - 00:00


Inditex keeps the tills ringing in run-up to Christmas

INDUSTRIA DE DISEÑO TEXTIL / INDITEX (ITX:BME) €27.50

Gain to date: 14.6%
Original entry point: Buy at €24, 8 October 2020


Spanish fashion...

Thu, 17/12/2020 - 00:00


Surge in Airbnb and DoorDash stock renews tech bubble debate

One of the most hotly awaited stock market debuts sparked the predicted frenzy by investors as accommodation booking platform Airbnb began trading on Nasdaq.

After netting one...

Thu, 17/12/2020 - 00:00


Buy into the structurally-driven Ideagen growth story

Whatever the relationship between the EU and UK on 1 January 2021, organisations will still need ways to manage the complex maze of bureaucracy and...

Thu, 17/12/2020 - 00:00


magazine 17 Dec 2020

Download PDF Page flip version

Investment outlook: 10 big questions for 2021. From considering vaccine setbacks and the impact of Brexit to whether tech is a winning trade again and Biden reshapes America, read Shares’ in-depth look at the key issues for the year ahead.

Elsewhere, find out why you shouldn’t expect a return to normal for bank dividends just yet.

Pages